Perry J, Chen A, Kariyawasam V, Collins G, Choong C, Teh WL, Mitrev N, Kohler F, Leong RWL (2018) Medication non-adherence in inflammatory bowel diseases is associated with disability. Intest Res 16(4):571–578

Article  PubMed  PubMed Central  Google Scholar 

Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12(12):720–727

Article  PubMed  Google Scholar 

van der Have M, Oldenburg B, Kaptein AA, Jansen JM, Scheffer RC, van Tuyl BA, van der Meulen-de Jong AE, Pierik M, Siersema PD, van Oijen MG et al (2016) Non-adherence to anti-TNF therapy is associated with illness perceptions and clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study. J Crohns Colitis 10(5):549–555

Article  PubMed  PubMed Central  Google Scholar 

Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hebuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L et al (2018) Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 67(1):53–60

Article  CAS  PubMed  Google Scholar 

Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD et al (2007) Adalimumab for maintenance of clinical response and remission in patients with Crohnʼs disease: the CHARM trial. Gastroenterol 132(1):52–65

Article  CAS  Google Scholar 

Panaccione R, Colombel JF, Sandborn WJ, D’Haens G, Zhou Q, Pollack PF, Thakkar RB, Robinson AM (2013) Adalimumab maintains remission of Crohnʼs disease after up to 4 years of treatment: data from CHARM and ADHERE. Aliment Pharmacol Ther 38(10):1236–1247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sparrow MP (2017) Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target. Expert Opin Biol Ther 17(5):613–621

Article  CAS  PubMed  Google Scholar 

M’Koma AE (2013) Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol 6:33–47

Article  PubMed  PubMed Central  Google Scholar 

Panaccione R, Colombel JF, Sandborn WJ, Rutgeerts P, D’Haens GR, Robinson AM, Chao J, Mulani PM, Pollack PF (2010) Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohnʼs disease. Aliment Pharmacol Ther 31(12):1296–1309

Article  CAS  PubMed  Google Scholar 

Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D’Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J et al (2009) Adalimumab for the treatment of fistulas in patients with Crohnʼs disease. Gut 58(7):940–948

Article  CAS  PubMed  Google Scholar 

Pillai N, Dusheiko M, Burnand B, Pittet V (2017) A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS ONE 12(10):e0185500

Article  PubMed  PubMed Central  Google Scholar 

Chan W, Chen A, Tiao D, Selinger C, Leong R (2017) Medication adherence in inflammatory bowel disease. Intest Res 15(4):434–445

Article  PubMed  PubMed Central  Google Scholar 

Lopez A, Billioud V, Peyrin-Biroulet C, Peyrin-Biroulet L (2013) Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review. Inflamm Bowel Dis 19(7):1528–1533

Article  PubMed  Google Scholar 

Fidder HH, Singendonk MM, van der Have M, Oldenburg B, van Oijen MG (2013) Low rates of adherence for tumor necrosis factor-alpha inhibitors in Crohnʼs disease and rheumatoid arthritis: results of a systematic review. World J Gastroenterol 19(27):4344–4350

Article  PubMed  PubMed Central  Google Scholar 

Govani SM, Noureldin M, Higgins PDR, Heisler M, Saini SD, Stidham RW, Waljee JF, Waljee AK (2018) Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases. Am J Gastroenterol 113(2):276–282

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457

Article  Google Scholar 

Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, Sandborn WJ, Feagan BG (2015) C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol 110(6):802–819

Article  PubMed  Google Scholar 

Chang S, Malter L, Hudesman D (2015) Disease monitoring in inflammatory bowel disease. World J Gastroenterol 21(40):11246–11259

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harvey RF, Bradshaw JM (1980) A simple index of Crohnʼs-disease activity. Lancet 1(8167):514

Article  CAS  PubMed  Google Scholar 

Best WR (2006) Predicting the Crohnʼs disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 12(4):304–310

Article  PubMed  Google Scholar 

Walmsley RS, Ayres RC, Pounder RE, Allan RN (1998) A simple clinical colitis activity index. Gut 43(1):29–32

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH (2009) A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 7(10):1081–1088

Article  PubMed  Google Scholar 

Catalan VS, LeLorier J (2000) Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 3(6):417–426

Article  CAS  PubMed  Google Scholar 

Gendelman O, Weitzman D, Rosenberg V, Shalev V, Chodick G, Amital H (2018) Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab. Br J Clin Pharmacol 84(4):786–795

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horne R (2006) Compliance, adherence, and concordance: implications for asthma treatment. Chest 130(1 Suppl):65S-72S

Article  PubMed  Google Scholar 

Panaccione R, Lofberg R, Rutgeerts P, Sandborn WJ, Schreiber S, Berg S, Maa JF, Petersson J, Robinson AM, Colombel JF (2019) Efficacy and safety of adalimumab by disease duration: analysis of pooled data from Crohnʼs disease studies. J Crohns Colitis 13(6):725–734

Article  PubMed  PubMed Central  Google Scholar 

Dutch Society of Gastroenterologists [Nederlandse Vereniging van Maag-Darm-Leverartsen] (2008) Richtlijn diagnostiek en behandeling van inflammatoire darmziekten bij volwassenen [in Dutch]. https://richtlijnendatabase.nl/gerelateerde_documenten/f/25979/Richtlijn%202009%20IBD%20volwassenen.pdf. Accessed 2 Oct 2023

Lichtenstein GROA, Travers S et al (2006) Factors associated with the development of intestinal strictures or obstructions in patients with Crohnʼs disease. Am J Gastroenterol 101(5):1030–1038

Article  PubMed  Google Scholar 

Dutch Society of Gastroenterologists [Nederlandse Vereniging van Maag-Darm-Leverartsen] (2014–2015) Handleiding behandeling IBD: Moderniseren van de richtlijn IBD [in Dutch]. https://www.crohn-colitis.nl/wp-content/uploads/2020/06/Modernisering-IBD-richtlijn-volwassenen-2009.pdf. Accessed 2 Oct 2023

Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K et al (2020) Risk factors for medication nonadherence to self-injectable biologic therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis 26(2):314–320

Article  PubMed  Google Scholar 

Murage MJ, Tongbram V, Feldman SR, Malatestinic WN, Larmore CJ, Muram TM, Burge RT, Bay C, Johnson N, Clifford S et al (2018) Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Prefer Adherence 12:1483–1503

Article  PubMed  PubMed Central  Google Scholar 

Anghel LA, Farcas AM, Oprean RN (2019) An overview of the common methods used to measure treatment adherence. Med Pharm Rep 92(2):117–122

PubMed  PubMed Central  Google Scholar 

Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

Article  CAS  PubMed  Google Scholar 

Iglay K, Cao X, Mavros P, Joshi K, Yu S, Tunceli K (2015) Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther 37(8):1813–1821

Article  PubMed  Google Scholar 

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d’Haens G, Hoentjen F, Hommes DW et al (2017) Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease. BMJ Open 7(11):e016695

Article  PubMed  PubMed Central  Google Scholar 

Schultheiss JPD, Altena S, Clevers MR, Baas D, Jharap B, Fidder HH (2021) Adherence to adalimumab was not improved by a reminder-based intervention with an electronic needle container. Dig Dis Sci 66(5):1477–1487

Article  CAS  PubMed  Google Scholar 

Romero-Jimenez R, Escudero-Vilaplana V, Chamorro-de-Vega E, Ais-Larisgoitia A, Lobato-Matilla E, Somoza-Fernandez B, Ruiz-Briones P, Gonzalez C, Baniandres O, Menchen L et al (2022) Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare. Front Immunol 13:915578

Article  CAS  PubMed  PubMed Central